SIAPS and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides a collection of examples of strategies and approaches for strengthening governance in pharmaceutical systems. The compendium highlights accumulated insights into factors that may have enabled or constrained the success of governance improvement initiatives. The intention is to systematically bolster knowledge, in alignment with USAID’s collaborating, learning, and adapting approach, so that stakeholders may examine the applicability of lessons learned and apply them in different settings to maximize resources and attain better development results. The compendium begins by defining governance, then explains its importance in pharmaceutical systems and introduces the framework SIAPS has used to guide its governance strengthening activities. It presents eight case studies on SIAPS’ work in enhancing governance in pharmaceutical systems, summarizes challenges commonly encountered and lessons learned, and closes with some reflections on the usefulness of SIAPS’ governance-strengthening framework.
Project Dates: September 2012 – September 2016
Manuel de procédures de gestion des achats et des stocks des produits de santé de lutte contre le VIH/SIDA
Ce manuel de procédures de Gestion des Achats et des Stocks (GAS) des produits de lutte contre le VIH/Sida vise à décrire d’une manière synthétique les procédures à suivre par le GTC-CNLS, la Centrale Nationale d’Approvisionnement en Médicaments et consommables médicaux Essentiels (CENAME), les Centres d’Approvisionnement Pharmaceutique Régionaux (CAPR) et les Formations Sanitaires (FOSA) lors des activités liées à la gestion des achats et des stocks des produits de santé de lutte contre le VIH/Sida acquis dans le cadre de la subvention de la série 10 du Fonds mondial de Lutte contre le VIH/SIDA, la Tuberculose et le Paludisme.
Deployment of the HIV and AIDS Commodity Management Tool OSPSIDA in Six Focus Countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo
The availability and quality of HIV commodity, including antiretrovirals and HIV test kits, increases the demand for HIV care services and enables the scale-up of antiretroviral therapy. In West Africa and Central Africa, stock-outs often occurred because of poor coordination and information sharing among partners and lack of a reliable early warning system.
With funding from USAID West Africa and in collaboration with West African Health Organization and key stakeholders involved in the procurement and supply management at country and regional levels, SIAPS has provided supports to six countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo. These countries will set up a web-based early warning system known as the HIV and AIDS Commodity Management Tool (OSPSIDA) to monitor HIV and AIDS commodities.
Transition of the HIV and AIDS Commodity Management Tool (OSPSIDA) to the West African Health Organization and Cameroon: Lessons Learned and Recommendations
USAID’s West African office asked SIAPS to provide support to six countries in the West and Central African region—Burkina Faso, Benin, Cameroon, Guinea, Niger, and Togo—to establish a web-based regional dashboard (OSPSIDA.org) that will create an early warning system (EWS) to monitor HIV and AIDS commodities and to detect and minimize the risk of stock-out in the focus countries.
In pursuit of this objective, and to ensure local ownership and long-term sustainability, the West African Health Organization (WAHO) has been involved since the project’s inception and has provided useful input during the design phase and official launch in Accra in April 2014. However, for the long-term sustainability of the dashboard and in an effort to support WAHO’s strategy of setting up security stock for West African countries, it is necessary to transfer the dashboard to WAHO’s Essential Medicines and Vaccines Program as its final home.
Establishing Pooled Procurement Systems among Faith-Based Organizations: A Guidance Document for Successful Implementation
Faith-based organizations play a vital role in many developing countries in ensuring access to essential medicines and delivering health services to patients. This is particularly the case in rural areas, where public health facilities do not exist or are inadequate. However, many faith-based organizations face challenges with providing a continuous supply and reliable availability of essential medicines. The influx of poor-quality (counterfeit) medicines on the African continent is also a growing challenge. Furthermore, weak regulatory systems, poor enforcement of regulatory laws, and challenges associated with procurement and distribution of medicines by faith-based organization in many countries have resulted in varying approaches and designs of procurement mechanisms in this sector that are inefficient and not cost-effective.
Alerts on stock-outs of lifesaving antiretrovirals emerged in a number of countries in the West African region in 2012 and 2013. Several root causes for this have been identified, including a lack of tools to improve the sharing of HIV and AIDS commodity information among stakeholders for faster decision making. This greatly affects the ability of partners to anticipate the needs of the host country, leads to delays in providing support, and creates doubt in the mind of the donors as to actual needs.
The USAID-funded SIAPS Program, implemented by Management Sciences for Health, has provided support to six countries in West and Central Africa—Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo—to set up a web-based EWS to monitor HIV and AIDS commodities.
Addressing the Unmet Need for ART among HIV+ Women and Newborns in Cameroon through Strengthening the Supply Chain of PMTCT Commodities
The Government of Cameroon and its partners have made major investments in the last decade in prevention, treatment, and care of HIV-infected patients. However, unmet need for antiretroviral therapy (ART) among HIV-positive pregnant women remains high at 66%. Critical to satisfying this need is ensuring adequate availability of prevention of mother-to-child transmission (PMTCT) commodities for rollout of new Option B+ guidelines. The Cameroon supply system consists of a cost recovery system for essential medicines and other health commodities and a free-of-charge system for priority commodities including those for PMTCT and ART. This study examines options for improving the supply and availability of these commodities.
Emmanuel Nfor, SIAPS Principal Technical Advisor and Head of the Supply Chain Management Cluster, will present today at the 8th Annual International AIDS Society Conference on HIV Pathogenisis, Treatment, and Prevention (IAS 2015). Nfor’s poster presentation focuses on improving supply chain management for antiretroviral therapy (ART) commodities among women and newborns in Cameroon, where unmet […]
Facility-Level Practices and Behaviors That Affect Performance of the Antiretroviral Medicine Supply Chain
In an effective supply chain there are timely and efficient flows of information (on commodities and patients) and quality products between the supplying units (central and regional medical stores [CMS/RMS]) and the health facilities. Although much has been learned about how to measure, monitor, and improve supply chain performance for antiretrovirals (ARVs) at the central and regional levels, less has been done to identify and measure “downstream factors” at the health facility that have an impact on the performance of the “upstream” (central) supply chain indicators.
The aim of this activity is to identify and define facility-level practices that have an impact on the supply chain, determine how these practices are linked with central-level supply chain performance measures, and propose a methodology and study design for a rigorous, empirical study to understand and estimate the impact on the identified facility-level behaviors and practices and central-level supply chain performance. Linking facility-level practices and behaviors to the “upstream” supply chain measures will substantially support efforts to improve the performance of the supply chain, such as the accuracy of quantification and forecasting activities.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]